この論文をさがす
説明
Basiliximab is potent, relatively safe immunosuppressive induction agent used in transplantation. Prophylactic use at the time of transplantation has been advocated to improve allograft outcomes. We report two cases of kidney transplant recipients with anaphylactic reactions after initial exposure to Basiliximab.
収録刊行物
-
- Transplantation Proceedings
-
Transplantation Proceedings 39 3457-3459, 2007-12-01
Elsevier BV